Methotrexate Impurity 22 | CAS 13726-52-8 - Request Quote
Methotrexate Impurity 22
| SZ CAT No: | SZ-M019068 |
| CAS No | 13726-52-8 |
| Mol.F. | C16H22N2O5 |
| Mol.Wt. | 322.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Methotrexate Impurity 22 is chemically Diethyl (4-aminobenzoyl)-L-glutamate. Methotrexate Impurity 22 is supplied with detailed characterization data compliant with regulatory guideline. Methotrexate Impurity 22 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Methotrexate.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 13726-52-8
Purchase 13726-52-8
Order 13726-52-8
Enquire 13726-52-8
price of 13726-52-8
13726-52-8 Supplier
13726-52-8 Manufacturer
13726-52-8 Exporter
buy high quality Methotrexate Impurity 22
Purchase Methotrexate Impurity 22
Methotrexate Impurity 22 suppliers
Methotrexate Impurity 22 manufacturers
Methotrexate Impurity 22 price
Order Methotrexate Impurity 22
Enquire Methotrexate Impurity 22
Methotrexate Impurity 22 cost
Methotrexate Impurity 22 Supplier
Methotrexate Impurity 22 Distributor
Methotrexate Impurity 22 for Method Validation
Methotrexate Reference Standard
Methotrexate Impurity 22 for ANDA Filing
Methotrexate Impurity 22 for Forced Degradation Studies
Methotrexate Impurity 22 Identification Standards
Methotrexate Impurity 22 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.